As more patients request direct-to-consumer (DTC) lab tests, medical laboratories will need to reconfigure and upgrade key aspects of their business in order to serve these new healthcare consumers properly. No longer a pure business-to-business endeavor, labs are now finding themselves in the consumer market.
Direct-to-consumer health startup Hims bought dermatology business Apostrophe. It’s part of a broader push by the company to expand into more indications.
As technology advances, AI-powered tools will increasingly reduce the administrative burdens on healthcare providers.
The startup, which currently has four direct-to-consumer brands, recently passed a $1 billion valuation. It plans to use the funds to market its services to a new customer: health plans.
The direct-to-consumer health startup recently acquired Modern Fertility, a startup with a similar business model. The startup’s founders will lead Ro’s women’s health business.
Sesame, a startup building a cash-pay marketplace for healthcare, raised $24 million. The sudden adoption of telehealth by the broader public led the startup to grow faster than expected.
Ro, a direct-to-consumer health startup, recently raised a $500 million funding round. It plans to use the funds to expand into at-home diagnostics and care.
Hear executives from Quantum Health, Surescripts, EY, Clinical Architecture and Personify Health share their views on digital transformation in healthcare.
Thirty Madison launched a new telehealth brand for people with seasonal allergies. It’s the latest addition to the company’s growing list of direct-to-consumer brands, which include hair loss, migraines and acid reflux.
Plume raised $14 million in a series A round led by Craft Ventures. The startup provides gender-affirming care services for the transgender community.
Folx, a direct-to-consumer health startup for LGBTQ patients, raised $25 million in funding. The company, which launched in December and currently operates in 11 states, plans to use the funds to further expand its footprint and expand into sexual health and family planning services.
Direct-to-consumer health startup Ro is reportedly in talks go public through a merger with a blank-check company, according to a report by Reuters.
The future looks bright for the integrated specialty pharmacy model – for health systems, providers, and most importantly, for patients.